Participants who were in the intervention arm were given the intermittent Continuous Glucose Monitoring for about 6 days at their very first visit for pregnancy which was at 2 months. This was then followed by those at 12, 21, 27 and lastly 33 weeks beside the routine care during pregnancy [1] . Women were asked to continuously use the real-time Continuous Glucose Monitoring more so on the hypoglycemia unawareness cases. The real-time Continuous Glucose Monitoring was not charged irrespective of the number of periods of monitoring. In the control arm, blinded real-time Continuous Glucose Monitoring was not carried out [2] .

During the first visit, allocation of women to intervention where they have received education about sensor insertion as well as the system of maintenance the basis of one on one for about 1 to 2 hours by a well-trained caregiver of diabetes [3] . Women were given instructions to keep performing self-monitored plasma measurements of glucose just as it is recommended and to ensure they verify their real-time Continuous Glucose Monitoring glucose values accuracy. Women who had real-time Continuous Glucose Monitoring alarms together with a subsequent glucose plasma of <4.0 mmol/L were advised to supplement their carbohydrate intake [4] .

Each and every woman received a phone call which was scheduled after the first insertion of the sensor. Contacting of the clinic by the patients was encouraged at any time they felt like and visits were paid to them during the weekdays. Most women preferred that the insertion of the sensor be in the abdominal skin [5] . However, in late pregnancy during caesarean or labor, some preferred it to be inserted in the upper arm. In the arm of intervention, participants were given real-time intermittent Continuous Glucose Monitoring for six days during first pregnancy visit at 12, 8, 27, 21 and 33 weeks together with the routine pregnancy care [6] . Continuous use of real-time Continuous Glucose Monitoring was encouraged in women especially those who had hypoglycemia unawareness. Apart from the real-time glucose monitoring, 30 women received other medication. They received antihypertensive treatment. Of the women, 8 were treated with medicine that was antidepressive six of which were serotine selective.

A program that is computer-generated was employed thus; allocation of treatment was concealed by the help of a phone automated service allocation that was given by the organization. Stratifying of those participating was done with respect to the diabetes type. Arm allocation to the women was done by research personnel who were trained.

Women who had type one diabetes were 123 while those who had type two diabetes were 31. The self-monitored measurements of plasma glucose were documented for 7 times a day in relation to each and every study visit in the two arms. This is presented in Table 1. The real-time Continuous Glucose Monitoring was started at just the first visit of pregnancy in all the 79 women allocated to be intervened and which was without much side effects generally. Sixty-four percent women with either of the two diabetes types used the real-time Continuous Glucose Monitoring per each protocol. A nearly continuous real-time Continuous Glucose Monitoring use was chosen by only 7% of the women see Figure 1.

The self-monitored glucose values of plasma, as well as plasma glucose biochemical profiles of the hyperglycemia were same throughout pregnancy in women who used the real-time Continuous Glucose Monitoring in comparison with the subject controls for the population entirely of study [7] . The results of the glycemic control have been presented in Table 2. The results revealed that 16% of women that experienced severe hypoglycemia see Figure 2.

Of the 154 pregnancies, 5 resulted in miscarriages while 149 were births that were live. In both arms, large for gestational age infants were the same in the two arms and there was no difference between the secondary outcomes that were predefined. The same results were recorded in the women who had type one diabetes [8] .

Congenital malfunctions happened in two infants. These were from women who had type one diabetes. A single occurrence of death that was prenatal occurred for a short time after the delivery of the infant by a woman who had type two diabetes as a result for severe dystocia of the shoulders. The results are shown in Table 3 and Figure 3.